![]() |
|
![]() |
| Home | About and More Information | Transporter Data Index |
No substrate information.
No inhibitor information.
| DDI | Implicated Transporter* | Interacting Drug | Affected Drug | AUC | Cmax | CLR | CL/F | t1/2 | Effect on PD | Reference | More Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical PK Impact(fold change) | |||||||||||
| 1 | OATP1B1, OATP1B3,OATP2B1 | Rifamin | Pitavastatin | 5.70 | 4.36 | ND | ND | 0.75 | Prueksaritanont, 2014 | DDI 1 | |
| 2 | OATP1B1, OATP1B3,OATP2B1 | Rifamin | Rosuvastatin | 4.37 | 9.93 | ND | ND | 0.24 | Prueksaritanont, 2014 | DDI 2 | |
PK = pharmacokinetic
The transporters are implicated by in vitro data and/or studies in humans with genetic polymorphisms of the transporter
DDI = Drug Drug Interaction
PD = pharmacodynamic
ND = not determined
NS = not significant
N/A = information not available
Calculation of Fold Change: fold change in the presence of the interacting drug = (value with interacting drug)/(value without interacting drug)
fold change > 1: increase in pharmacokinetic value
fold change < 1: decrease in pharmacokinetic value